JP2018525032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018525032A5 JP2018525032A5 JP2018521710A JP2018521710A JP2018525032A5 JP 2018525032 A5 JP2018525032 A5 JP 2018525032A5 JP 2018521710 A JP2018521710 A JP 2018521710A JP 2018521710 A JP2018521710 A JP 2018521710A JP 2018525032 A5 JP2018525032 A5 JP 2018525032A5
- Authority
- JP
- Japan
- Prior art keywords
- conjugate
- pharmaceutical composition
- disease
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1512486.0A GB201512486D0 (en) | 2015-07-16 | 2015-07-16 | IL22 immunoconjugates |
| GB1512486.0 | 2015-07-16 | ||
| GB1517649.8 | 2015-10-06 | ||
| GBGB1517649.8A GB201517649D0 (en) | 2015-10-06 | 2015-10-06 | IL22 Immunoconjugates |
| GBGB1521470.3A GB201521470D0 (en) | 2015-12-04 | 2015-12-04 | IL22 immunoconjugates |
| GB1521470.3 | 2015-12-04 | ||
| PCT/EP2016/066979 WO2017009469A1 (en) | 2015-07-16 | 2016-07-15 | Il22 immunoconjugates |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018525032A JP2018525032A (ja) | 2018-09-06 |
| JP2018525032A5 true JP2018525032A5 (cg-RX-API-DMAC10.html) | 2020-02-06 |
| JP6735822B2 JP6735822B2 (ja) | 2020-08-05 |
Family
ID=56413683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521710A Expired - Fee Related JP6735822B2 (ja) | 2015-07-16 | 2016-07-15 | Ｉｌ２２免疫コンジュゲート |
Country Status (21)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3091139A1 (en) * | 2018-02-21 | 2019-08-29 | Genentech, Inc. | Dosing for treatment with il-22 fc fusion proteins |
| WO2020249757A1 (en) | 2019-06-14 | 2020-12-17 | Philogen S.P.A | Immunoconjugates comprising a single chain diabody and interleukin-15 or interleukin-15 and a sushi domain of interleukin-15 receptor alpha |
| EP4185615A1 (en) | 2020-07-22 | 2023-05-31 | Philogen S.p.A. | Treatment of pulmonary hypertension |
| US12240879B2 (en) | 2020-07-30 | 2025-03-04 | Anwita Biosciences, Inc. | Interleukin-22 fusion proteins, and their pharmaceutical compositions |
| WO2022073038A1 (en) * | 2020-10-02 | 2022-04-07 | Abbvie Inc. | Interleukin-22 (il-22) fusion proteins and uses thereof |
| CN115703841A (zh) * | 2021-08-10 | 2023-02-17 | 复旦大学 | 白介素17a抗体与白介素22细胞因子融合蛋白及其制备方法与用途 |
| US20250197485A1 (en) | 2022-03-17 | 2025-06-19 | Universitätsklinikum Jena | Anti-ED-A Antibodies for the Treatment of Pulmonary Hypertension |
| WO2025101842A1 (en) * | 2023-11-09 | 2025-05-15 | Flagship Pioneering Innovations Vii, Llc | Compositions and methods for targeted delivery of therapeutic agents |
| WO2026003203A1 (en) | 2024-06-27 | 2026-01-02 | Philogen S.P.A. | Combination of an immunocytokine comprising targeted il2 and a jak inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2552590A1 (en) | 2004-01-05 | 2005-07-21 | Emd Lexigen Research Center Corp. | Interleukin-12 targeted to oncofoetal fibronectin |
| EP1831254B1 (en) | 2004-12-23 | 2012-06-06 | Molmed SpA | Conjugation product |
| US20060263368A1 (en) * | 2005-01-10 | 2006-11-23 | Research Development Foundation | Targeted chimeric molecules for cancer therapy |
| MX2007013875A (es) | 2005-05-11 | 2008-01-28 | Philogen Spa | Proteinas de fusion del anticuerpo l19 contra fibronectina ed-b e interlucina 12. |
| CA2682851C (en) | 2007-04-02 | 2017-01-17 | Philogen S.P.A. | A novel antigen associated with the neovasculature of tumour metastases |
| EA017995B1 (ru) | 2007-07-25 | 2013-04-30 | Филоджен С.П.А. | Антиген, связанный с вариантами рака легкого и лимфомами |
| EP2209805B1 (en) | 2007-10-30 | 2017-09-06 | Philogen S.p.A. | An antigen associated with rheumatoid arthritis |
| US20130121959A1 (en) | 2010-01-13 | 2013-05-16 | Joseph R. Maxwell | Il-22-fc and hepcidin activity |
| TWI500427B (zh) * | 2010-05-14 | 2015-09-21 | Abbvie Inc | Ｉｌ－１結合蛋白 |
| PL2970422T3 (pl) * | 2013-03-15 | 2018-09-28 | F.Hoffmann-La Roche Ag | Polipeptydy IL-22 i białka fuzyjne IL-22 Fc i sposoby zastosowania |
| JP2016519111A (ja) * | 2013-04-26 | 2016-06-30 | フィロゲン エスピーエー | 細胞外マトリックス成分に対する抗体にコンジュゲートしたｉｌ４ |
| CN104623639A (zh) * | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | 白介素22二聚体在制备治疗胰腺炎药物中的应用 |
-
2016
- 2016-07-15 RU RU2018105687A patent/RU2018105687A/ru not_active Application Discontinuation
- 2016-07-15 AU AU2016293114A patent/AU2016293114A1/en not_active Abandoned
- 2016-07-15 ES ES16739166T patent/ES2778430T3/es active Active
- 2016-07-15 CA CA2992366A patent/CA2992366A1/en not_active Abandoned
- 2016-07-15 MX MX2018000687A patent/MX2018000687A/es unknown
- 2016-07-15 KR KR1020187004633A patent/KR20180030180A/ko not_active Withdrawn
- 2016-07-15 WO PCT/EP2016/066979 patent/WO2017009469A1/en not_active Ceased
- 2016-07-15 JP JP2018521710A patent/JP6735822B2/ja not_active Expired - Fee Related
- 2016-07-15 CR CR20180087A patent/CR20180087A/es unknown
- 2016-07-15 CN CN201680041884.2A patent/CN108137667A/zh active Pending
- 2016-07-15 PE PE2018000073A patent/PE20180797A1/es unknown
- 2016-07-15 EP EP16739166.3A patent/EP3322719B1/en active Active
- 2016-07-15 HK HK18109660.0A patent/HK1250237A1/zh unknown
- 2016-07-15 BR BR112018000909A patent/BR112018000909A2/pt not_active Application Discontinuation
-
2017
- 2017-05-30 US US15/608,689 patent/US10246502B2/en not_active Expired - Fee Related
-
2018
- 2018-01-11 IL IL256849A patent/IL256849A/en unknown
- 2018-01-15 DO DO2018000019A patent/DOP2018000019A/es unknown
- 2018-01-15 CL CL2018000131A patent/CL2018000131A1/es unknown
- 2018-01-16 PH PH12018500131A patent/PH12018500131A1/en unknown
- 2018-01-17 CO CONC2018/0000414A patent/CO2018000414A2/es unknown
- 2018-02-09 EC ECIEPI201810616A patent/ECSP18010616A/es unknown
-
2019
- 2019-02-20 US US16/280,427 patent/US10858411B2/en not_active Expired - Fee Related